Further processing options
First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open...
Saved in:
Journal Title: | Annals of Oncology |
---|---|
Authors and Corporations: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
In: | Annals of Oncology, 28, 2017, 10, p. 2443-2450 |
Type of Resource: | E-Article |
Language: | English |
published: |
Elsevier BV
|
Subjects: |